Estrella Immunopharma, Inc.ESLANASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-8.85M
↓ 151% below average
Average (4y)
$-3.52M
Historical baseline
Range
High:$-11160.00
Low:$-8.85M
CAGR
+86.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-8.85M | -21.0% |
| 2023 | $-7.31M | -964.1% |
| 2022 | $-686971.00 | -6055.7% |
| 2021 | $-11160.00 | +98.5% |
| 2020 | $-733693.00 | - |